SARS, SARS‑CoV‑2 and other sarbecoviruses keep showing how disruptive this viral group can be. Their continued evolution underlines why vaccines aiming for broad, cross‑sarbecovirus protection matter so much for future preparedness. Paper: https://www.journalofinfection.com/article/S0163-4453(26)00084-8/fulltextt